A Phase 1B/2. Multiccenter,Doubleblind Placebo-controlled, Randomized, Single-Ascending dose study to assess the safety, Pharmacokinetics and pharmacodynamics of DS-1040B in Subjects with Acute Ischemic Stroke.
Clinical Trial Grant
Administered By
Neurology, Neurocritical Care
Awarded By
Daiichi Sankyo Inc
Start Date
February 1, 2016
End Date
December 31, 2019
Administered By
Neurology, Neurocritical Care
Awarded By
Daiichi Sankyo Inc
Start Date
February 1, 2016
End Date
December 31, 2019